Recall Register

Food, drugs, devices › Smiths Medical ASD, Inc.

Device recall: CADD" Medication Cassette Reservoir, 50mL, REF 21-7001-24 & 21-7301-24, Sterile EO, Rx only.

FDA enforcement event 70402 · Class II · initiated 2 Feb 2015 · status Terminated · terminated 18 Mar 2016

DeviceVoluntary: Firm initiated1 product recordSaint Paul, MN

Smiths Medical ASD, Inc. (Saint Paul, MN) initiated this device recall on 2 Feb 2015; FDA lists 1 product record under event 70402, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 18 Mar 2016. Initiation: voluntary: firm initiated. Smiths Medical ASD, Inc. has 108 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Smiths Medical ASD, Inc., Saint Paul, MN.

Reason for recall

"Smiths Medical has become aware of an issue with specific lots of 50mL CADD" Medication Cassette Reservoirs (Cassette). Some Cassettes may leak at the sealing area of the pump tube and medication bag. Smiths Medical has received no reports of serious injury or death related to this issue."

Distribution

"Worldwide Distribution - US (nationwide) Distribution to the states of : AL, AZ, AR, CA, CO, CT, FL, GA, HI, IL IN, IA, MD, MA, MN, MS, MO, NE, NV, NH ,NJ, NM, NY, NC, OH, OR, PA, SD, TN, TX, UT, VA…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1286-2015CADD" Medication Cassette Reservoir, 50mL, REF 21-7001-24 & 21-7301-24, Sterile EO, Rx only.48,208 (17,040 US, 31,168 OUS).Class IITerminated25 Mar 2015

Context

91%of 2015 device events are Class II1,153 events that year
1product record in this eventfirm median: 1
108events on this register for the firm

Other enforcement events for Smiths Medical ASD, Inc.

InitiatedProduct (first record)TypeClassRecords
10 Apr 2025CADD Solis HSPCA Pump ***Updated 5/27/26*** Scope updated to apply specifically to customers using the wireless system. DeviceClass I1
10 Apr 2025CADD-Solis Infusion Pump Models: 1) PUMP KIT, CADD-SOLIS, MDL 2110, V4.2, CE ENGLISH 1/EA, Model Number: 21-2111-0402-51DeviceClass I2
10 Apr 2025CADD-Solis HPCA Ambulatory Infusion Pump; Model/Number: 21-2111-0402-09-KYO 21-2111-0402-09-KYO CADD SOLIS PIB PUMP FOR DeviceClass I2
14 Feb 2025CAPNOCHECK BCI Airway Adapter; Model Number BSR; Product Code WW1100DeviceClass II2
13 Feb 2025smiths medical ProPort Plastic Venous Access System, Silicone Catheter, 2.87,,O.D. (8.4Fr) s 1.0mm I.D., REF 21-4150-24DeviceClass I12
13 Feb 2025Portex Endotracheal Tube, Item Codes 100/105/025 100/105/030 100/105/035 100/111/020 100/111/025 100/111/030 100/111/035DeviceClass I1
28 Oct 2024smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JPDeviceClass II3
24 Sep 2024medex TranStar Single OR Set 1/EA, Product Code REF MX20846R2DeviceClass II24
18 Jul 2024smiths medical portex, Nasopharyngeal Airway, Sizes as follows: a) AIRWAY NASOPHARYNGEAL 6.0MM, REF 100/210/060; b) AIRWDeviceClass II5
16 Jul 2024CADD-Solis Li-ion Rechargeable Battery Packs, REF 21-2160-XX, which are also sold as a component of the following CADD SDeviceClass I1

All 108 events for Smiths Medical ASD, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Smiths Medical has become aware of an issue with specific lots of 50mL CADD" Medication Cassette Reservoirs (Cassette). Some Cassettes may leak at the sealing area of the pump tube and medication bag. Smiths Medical has received no reports of serious injury or death related to this issue."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US (nationwide) Distribution to the states of : AL, AZ, AR, CA, CO, CT, FL, GA, HI, IL IN, IA, MD, MA, MN, MS, MO, NE, NV, NH ,NJ, NM, NY, NC, OH, OR, PA, SD, TN, TX, UT, VA…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 18 Mar 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.